Additionally, studies in aged APP/PS1 AD mouse models showed a reduction in Nrf2, NQO1, GCL catalytic subunit (GCLC), and GCL modifier subunit (GCLM) mRNA levels [67]. This evidence concerns the gene GCLC and Alzheimer disease.